Gambaran Kristaluria Pada Penderita Batu Saluran Kemih Di RSUP H. Adam Malik Medan
DAFTAR PUSTAKA
Abboud IA. Mineralogy and chemistry of urinary stones : patients from north
Jordan. Environ Geochem Health (2008) 30:445-463
Aggarwal KP, Shifa N, Monica K, Chanderdeep T. 2013.Nephrolithiasis:
Molecular Mechanism of Renal Stone Formation and the Critical Role
Played by Modulators.Uttrakhand, India.
Alaya, A, Nouri, A, Najjar, MF. 2010. Changes in stone composition according to
age and gender in Tunisian children. Journal of Pediatric Urology (2010) 6,
364-371.
Baker K, Costabile RA. Demographics, stone characteristic, and treatment of
urinary calculi at the 47th Combat Support Hospital during the first 6
months of Operation Iraqi Freedom. Mil Med. 2007;172(5):498-503.
Basavaraj DR, Biyani CS, Browning AJ, Cartledge JJ. 2007. The Role of Urinary
Kidney Stone Inhibitors and Promoters in the Pathogenesis of Calcium
Containing Renal Stones. United Kingdom.
Baumann JM, Affolter B, Casella R. 2011. Aggregation of freshly precipitated
calcium oxalate crystals in urine of calcium stone patients and controls. Urol
Res (2011) 39:421-427.
Brikowski TH, Yair L, Margaret SP. 2007. Climate-Related Increase in the
Prevalence of Urolithiasis in the United States. Texas, Dallas.
Brzica H, Breljak D, Burckhardt C, Burckhardt G, Sabolic I. Oxalate from the
environment to kidney stones. Brzica H, et al. oxalate urolithiasis. Arh Hig
Rada Toksikol 2013;64:609-630
Childs MA, Mynderse LA, Rangel LJ, Wilson TM, Lingeman JE, Krambeck AE.
2013. Pathogenesis of Bladder Calculi in the Presence of Urinary Stasis.
The Journal of Urology: Vol.189, 1347-1361.
Coe FL, Andrew E, Elaine W. 2014. Kidney Stone Disease. Illinois, USA.
Edvardsson, VO, et al. Hereditary causes of kidney stones and chronic kidney
disease. Pediatr Nephrol (2013) 28:1923-1942
27
28
Evan AP. 2010. Physiology and Etiology of Stone Formation in the Kidney and
the Urinary Tract.PediatrNephrol 25:831-841.
Fink. Recurrent Nephrolithiasis in Adults: Comparative Effectiveness of
Preventive Medical Strategies. 2013
Flagg RL. 2007. Dietary and Holistic Treatment of Recurrent Calcium Oxalate
Kidney Stones: Review of Literature to Guide Patient Education. Urologic
Nursing [1053-816X] Flagg, Laura R yr:2007 vol:27 iss:2 pg:113 -22, 143;
quiz 123.
Glenn S, B C. Campbell-Wals Urology: Evaluation of the Urologic Patients:
Hystory, Physical Examination, and Urinalysis. 10th ed. United States of
America: Elsevier; 2012. 73-98 p.
Grases F, Costa-Bauza A, Gomila I, Ramis M, Garcia-Raja A, Prieto M. Urinary
PH and renal lithiasis. Urol Res. 2012 40:41-46)
Herlitz, LC, et al. 2012. Crystalline Nephropathies. Arch Pathol Lab Med-Vol
136.
Hong YH, Dublin N, Razack AH, Mohd MA, Husain R. Urinary metabolic
evaluation
of
stone
formers-a
Malaysian
perspective.
Urology.
2012;80(3):529-34.
Ikatan Ahli Urologi Indonesia. 2007 IAUI . Guidelines Penatalaksaan Batu
Saluran Kemih . 2007
Lieske JC, Pena de la Vega LS, Slezak JM, Bergstralh EJ, Leibson CL, Ho KL, et
al. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney
Int. 2006;69(4):760-4.
López M, Bern H. 2010.History, Epidemiology and Regional Diversities of
Urolithiasis.PediatrNephrol 25: 49-59.
Luciano LR, Perazella MA, Crystalline-induced Kidney deisease : a case for
urinary microscopic.Clin Kidney J (2014) 0: 1–6
Madhavi C, Prathyusha, dan Rajender, S. 2012. Relationship Between Crystalluria
and Urinary Calculi and Associated Urinary Tract Infection. Hyderabad,
India.
29
Margaret S, L Y. Campbell-Wals Urology: Urinary Lithiasis: Etiology,
Epidemiology, and Pathogenesis. United States of America: Elsavier; 2012.
1257-86 p.
Marickar YM, Lekshmi PR, Varma L. 2009. Element distribution analysis of
urinary crystals. Urol Res (2009) 37:277-282.
Marickar YM, Salim A. 2009. Clinical risk index in urolothiasis. Urol Res (2009)
37:283-287.
Moe OW. Kidney stones: pathophysiology and medical management. Lancet.
2006;367(9507):333-44.
Pearle MS, Yair L. 2012. Urology Tenth Edition. Campbell-Walsh. Elsevier,
p1260.
Qiu,SR, Wierzbicki A, Orme CA, Cody AM, Hoyer JR, Nancollas GH, Zepeda S,
De Yoreo JJ. 2003. Molecular modulation of calcium oxalate crystallization
by osteopontin and citrate. California.
Robertson WG. 2004. Kidney models of cakcium oxalate formation. Nephron
Physiol 2004; 98:p21-30.
Seema L, Jawalekar, Vasant T, B A. Urinary Citrate excretion in patients with
Urolithiasis. ScienSage: Journal of Advanced Scientific Research. 2013:347.
Shaafie IA, Sreedharan J, Muttappallymyalil J, Venkatramana M, Freeg MAHA,
Mathew E. 2012. Effect of urinary pH and specific gravity in urolithiasis,
Ajman, UEA. Gulf Medical Journal 2012;1(1): 26-31
Sikora P, Zajackowsaka M, Hoppe B. Assement of crystallization risk formulas in
pediatric calcium stone-formers. Pediatr Nephro. 2009. 1997-2003
Strasinger, SK, Marjorie SDL. 2008. Urinalysis and Body Fluid. Fifth Edition.
Philadephia, USA.
Tanagho EA, McAninch, JW. Smith’s General Urology 17thedition. 2006
Tiselius HG. Epidemiology and medical management of stone disease. BJU Int.
2003;91(8):758-67.
Tiselius, HG. 2013. The role of calcium phosphate in the development of
Randall’s plaques. Urolithiasis (2013) 41:369-377.
30
Van Noord, C, Wulkan RW, van den Dorpel MA. 2012. Crystaluria. Netherland.
Wu W, Yang D, Tiselius HG, Ou L, Liang Y, Zhu H, et al. The characteristics of
the stone and urine composition in Chinese stone formers: primary report of
a single-center results. Urology. 2014;83(4):732-7.
Abboud IA. Mineralogy and chemistry of urinary stones : patients from north
Jordan. Environ Geochem Health (2008) 30:445-463
Aggarwal KP, Shifa N, Monica K, Chanderdeep T. 2013.Nephrolithiasis:
Molecular Mechanism of Renal Stone Formation and the Critical Role
Played by Modulators.Uttrakhand, India.
Alaya, A, Nouri, A, Najjar, MF. 2010. Changes in stone composition according to
age and gender in Tunisian children. Journal of Pediatric Urology (2010) 6,
364-371.
Baker K, Costabile RA. Demographics, stone characteristic, and treatment of
urinary calculi at the 47th Combat Support Hospital during the first 6
months of Operation Iraqi Freedom. Mil Med. 2007;172(5):498-503.
Basavaraj DR, Biyani CS, Browning AJ, Cartledge JJ. 2007. The Role of Urinary
Kidney Stone Inhibitors and Promoters in the Pathogenesis of Calcium
Containing Renal Stones. United Kingdom.
Baumann JM, Affolter B, Casella R. 2011. Aggregation of freshly precipitated
calcium oxalate crystals in urine of calcium stone patients and controls. Urol
Res (2011) 39:421-427.
Brikowski TH, Yair L, Margaret SP. 2007. Climate-Related Increase in the
Prevalence of Urolithiasis in the United States. Texas, Dallas.
Brzica H, Breljak D, Burckhardt C, Burckhardt G, Sabolic I. Oxalate from the
environment to kidney stones. Brzica H, et al. oxalate urolithiasis. Arh Hig
Rada Toksikol 2013;64:609-630
Childs MA, Mynderse LA, Rangel LJ, Wilson TM, Lingeman JE, Krambeck AE.
2013. Pathogenesis of Bladder Calculi in the Presence of Urinary Stasis.
The Journal of Urology: Vol.189, 1347-1361.
Coe FL, Andrew E, Elaine W. 2014. Kidney Stone Disease. Illinois, USA.
Edvardsson, VO, et al. Hereditary causes of kidney stones and chronic kidney
disease. Pediatr Nephrol (2013) 28:1923-1942
27
28
Evan AP. 2010. Physiology and Etiology of Stone Formation in the Kidney and
the Urinary Tract.PediatrNephrol 25:831-841.
Fink. Recurrent Nephrolithiasis in Adults: Comparative Effectiveness of
Preventive Medical Strategies. 2013
Flagg RL. 2007. Dietary and Holistic Treatment of Recurrent Calcium Oxalate
Kidney Stones: Review of Literature to Guide Patient Education. Urologic
Nursing [1053-816X] Flagg, Laura R yr:2007 vol:27 iss:2 pg:113 -22, 143;
quiz 123.
Glenn S, B C. Campbell-Wals Urology: Evaluation of the Urologic Patients:
Hystory, Physical Examination, and Urinalysis. 10th ed. United States of
America: Elsevier; 2012. 73-98 p.
Grases F, Costa-Bauza A, Gomila I, Ramis M, Garcia-Raja A, Prieto M. Urinary
PH and renal lithiasis. Urol Res. 2012 40:41-46)
Herlitz, LC, et al. 2012. Crystalline Nephropathies. Arch Pathol Lab Med-Vol
136.
Hong YH, Dublin N, Razack AH, Mohd MA, Husain R. Urinary metabolic
evaluation
of
stone
formers-a
Malaysian
perspective.
Urology.
2012;80(3):529-34.
Ikatan Ahli Urologi Indonesia. 2007 IAUI . Guidelines Penatalaksaan Batu
Saluran Kemih . 2007
Lieske JC, Pena de la Vega LS, Slezak JM, Bergstralh EJ, Leibson CL, Ho KL, et
al. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney
Int. 2006;69(4):760-4.
López M, Bern H. 2010.History, Epidemiology and Regional Diversities of
Urolithiasis.PediatrNephrol 25: 49-59.
Luciano LR, Perazella MA, Crystalline-induced Kidney deisease : a case for
urinary microscopic.Clin Kidney J (2014) 0: 1–6
Madhavi C, Prathyusha, dan Rajender, S. 2012. Relationship Between Crystalluria
and Urinary Calculi and Associated Urinary Tract Infection. Hyderabad,
India.
29
Margaret S, L Y. Campbell-Wals Urology: Urinary Lithiasis: Etiology,
Epidemiology, and Pathogenesis. United States of America: Elsavier; 2012.
1257-86 p.
Marickar YM, Lekshmi PR, Varma L. 2009. Element distribution analysis of
urinary crystals. Urol Res (2009) 37:277-282.
Marickar YM, Salim A. 2009. Clinical risk index in urolothiasis. Urol Res (2009)
37:283-287.
Moe OW. Kidney stones: pathophysiology and medical management. Lancet.
2006;367(9507):333-44.
Pearle MS, Yair L. 2012. Urology Tenth Edition. Campbell-Walsh. Elsevier,
p1260.
Qiu,SR, Wierzbicki A, Orme CA, Cody AM, Hoyer JR, Nancollas GH, Zepeda S,
De Yoreo JJ. 2003. Molecular modulation of calcium oxalate crystallization
by osteopontin and citrate. California.
Robertson WG. 2004. Kidney models of cakcium oxalate formation. Nephron
Physiol 2004; 98:p21-30.
Seema L, Jawalekar, Vasant T, B A. Urinary Citrate excretion in patients with
Urolithiasis. ScienSage: Journal of Advanced Scientific Research. 2013:347.
Shaafie IA, Sreedharan J, Muttappallymyalil J, Venkatramana M, Freeg MAHA,
Mathew E. 2012. Effect of urinary pH and specific gravity in urolithiasis,
Ajman, UEA. Gulf Medical Journal 2012;1(1): 26-31
Sikora P, Zajackowsaka M, Hoppe B. Assement of crystallization risk formulas in
pediatric calcium stone-formers. Pediatr Nephro. 2009. 1997-2003
Strasinger, SK, Marjorie SDL. 2008. Urinalysis and Body Fluid. Fifth Edition.
Philadephia, USA.
Tanagho EA, McAninch, JW. Smith’s General Urology 17thedition. 2006
Tiselius HG. Epidemiology and medical management of stone disease. BJU Int.
2003;91(8):758-67.
Tiselius, HG. 2013. The role of calcium phosphate in the development of
Randall’s plaques. Urolithiasis (2013) 41:369-377.
30
Van Noord, C, Wulkan RW, van den Dorpel MA. 2012. Crystaluria. Netherland.
Wu W, Yang D, Tiselius HG, Ou L, Liang Y, Zhu H, et al. The characteristics of
the stone and urine composition in Chinese stone formers: primary report of
a single-center results. Urology. 2014;83(4):732-7.